NCT00432068View on ClinicalTrials.gov

Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy Cholecystectomized
Interventions
DRUG

Octreotide pamoate

Trial Locations (6)

Unknown

Novartis Investigative Site, Ghent

Novartis Investigative Site, Wavre-Gelgique

Novartis Investigative Site, Lagord

Novartis Investigative Site, Paris

Novartis Investigative Site, Rennes

Novartis Investigative Site, Verona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY